ATG in allogeneic stem cell transplantation: standard of care in 2017? Counterpoint
- 28 March 2017
- journal article
- Published by American Society of Hematology in Blood Advances
- Vol. 1 (9) , 573-576
Abstract
Publisher9s Note: This article has a companion Point by Bacigalupo. Publisher9s Note: Join in the discussion of these articles at Blood Advances Community Conversations.Keywords
This publication has 30 references indexed in Scilit:
- Two days of antithymocyte globulin are associated with a reduced incidence of acute and chronic graft‐versus‐host disease in reduced‐intensity conditioning transplantation for hematologic diseasesCancer, 2012
- Low Risk of Chronic Graft-versus-Host Disease and Relapse Associated with T Cell–Depleted Peripheral Blood Stem Cell Transplantation for Acute Myelogenous Leukemia in First Remission: Results of the Blood and Marrow Transplant Clinical Trials Network Protocol 0303Transplantation and Cellular Therapy, 2011
- Horse versus Rabbit Antithymocyte Globulin in Acquired Aplastic AnemiaNew England Journal of Medicine, 2011
- Impact of immune modulation with anti–T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignanciesBlood, 2011
- High Rabbit-Antihuman Thymocyte Globulin Levels Are Associated with Low Likelihood of Graft-vs-Host Disease and High Likelihood of Posttransplant Lymphoproliferative DisorderTransplantation and Cellular Therapy, 2010
- High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host diseaseBlood, 2010
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation CyclophosphamideTransplantation and Cellular Therapy, 2008
- Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitroBlood, 2008
- Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemiaBlood, 2006
- A Novel Mechanism of Action for Anti-Thymocyte GlobulinJournal of the American Society of Nephrology, 2006